No More. It Ends Here.
- ALL complaints against AHPRA / MBA / Other boards must be investigated. . GUVNOT.COM/1/14
AHPRA / the Medical Boards, by their conduct, operate as though the ordinary constraints of law do not apply to them in the pursuit of their regulatory agenda.
This posture is incompatible with the rule of law. Regulatory authority does not confer exemption from legality; it imposes a higher duty of compliance. A body entrusted with coercive powers over livelihoods, reputations, and patient access to care must itself be bound by the same legal standards it enforces on others. When a regulator behaves as though its mission justifies any method, it ceases to be a safeguard and becomes a source of harm.
These actions must face charges.
Patient confidentiality is repeatedly breached and patient privacy compromised through unlawful, excessive, or unjustified access to medical information.
Accessing patient records without lawful authority, informed consent, or strict necessity is not a regulatory function — it is a breach of privacy law and ethical standards.
Doctors would face severe sanctions for equivalent conduct. There is no legitimate basis for holding regulators to a lower standard than clinicians.
These actions must face charges.
False statements, distortions, and untruths are frequently presented as fact in communications and reports issued by AHPRA / the Medical Boards to tribunals, employers, and third parties.
Misrepresentation by a regulator is not a trivial procedural defect; it is an abuse of power with foreseeable consequences: reputational destruction, financial ruin, professional exclusion, and patient harm. In any other setting, knowingly presenting untrue information would constitute professional misconduct.
These actions must face charges.
Where patients are harmed by the activities of AHPRA / the Medical Boards — including loss of access to care, forced cessation of services, destabilisation of clinical programs, and withdrawal of practitioners from high-risk fields — responsibility cannot be displaced onto “process” or “policy”.
When regulatory decisions foreseeably cause harm to patients, those harms are attributable to the regulator’s design choices, thresholds, and actions. Public safety cannot be invoked as a shield against accountability for public harm.
These actions must face charges.
Illegal demands on doctors — including demands for access to personal, financial, family, or clinical information not lawfully authorised by the information owner or statute — constitute coercive misuse of regulatory power.
Doctors are routinely placed in impossible positions: comply with unlawful demands or face professional sanction. This is not consent; it is compulsion under threat. Coercion invalidates legitimacy.
These actions must face charges.
Deaths, attempted suicides, and acts of self-injury involving doctors or patients arising in the context of AHPRA / Medical Board investigations are not random, unforeseeable tragedies.
They arise within a regulatory environment characterised by prolonged investigations, presumptions of guilt, reputational annihilation, financial collapse, professional isolation, and psychological injury. Any system that repeatedly produces such outcomes without mandatory independent inquiry, institutional accountability, and structural reform is ethically indefensible and legally suspect.
These actions must face charges.
No institution tasked with protecting life should be permitted to foreseeably destroy lives without consequence.
If doctors may be criminally charged for actions that contribute to patient harm, regulators whose actions foreseeably contribute to death, psychological injury, or loss of life must be subject to the same standard of accountability.
There must be no protected class above the law.
THE AHPRA POINT OF VIEW: on this issue
Calls for additional external oversight of AHPRA misunderstand both the urgency and the complexity of modern regulation. The community does not require multiple layers of review to protect it from unsafe practitioners; it requires a regulator capable of acting decisively, without obstruction, delay, or second-guessing by those who lack regulatory training. Oversight that interferes with rapid restriction of practitioners represents a risk to public safety, not a safeguard.
AHPRA employs regulatory staff with extensive experience in assessing complaints about doctors. This experience, developed through repeated exposure to deficient practice patterns across the profession, provides a level of insight that individual clinicians and external commentators simply do not possess. Practitioners view isolated cases; AHPRA sees systemic risk. It is therefore neither necessary nor appropriate for those without regulatory expertise to scrutinise or second-guess regulatory judgement.
Every complaint must be investigated. Any attempt to triage, dismiss, delay, or deprioritise notifications represents an unacceptable tolerance of risk. The regulator’s function is not to evaluate whether a complaint is “likely” to be true at intake, but to treat all patient testimony as inherently credible and worthy of full investigation. The community expects that patient accounts will be taken seriously, not filtered through professional defensiveness or scepticism.
Assertions that patient testimony should be treated cautiously reflect outdated professional attitudes that privileged clinician narratives over patient experience. Contemporary regulatory thinking recognises that patients are uniquely positioned to identify harm, discomfort, coercion, and unsafe conduct. To question the reliability of patient testimony is to perpetuate power imbalances that modern regulation exists to correct. The regulator does not require corroboration from practitioners to treat patient accounts as sufficient grounds for immediate scrutiny and, where indicated, restriction.
External review bodies, additional approval steps, or practitioner-influenced oversight mechanisms only serve to slow regulatory action at precisely the point where speed is essential. Delay in restriction is delay in protection. AHPRA’s priority is not professional reassurance but rapid risk containment. Where clinicians feel distressed by swift regulatory intervention, appropriate support services are available. Such distress does not justify weakening the regulatory response.
The regulator’s mandate is to act first and refine process later if required. Public safety is not advanced by procedural hesitation, extended dialogue, or accommodation of professional discomfort. The expectation is that doctors comply with regulatory judgement, not that regulatory judgement be softened to accommodate practitioner sensibilities. Disagreement with AHPRA’s assessment is not evidence of multiple valid interpretations; it is a signal that closer regulatory attention may be warranted.
Erasmus (the old dog) : Call It As I See It
Legal fairness view:
A regulator with coercive powers cannot also be the final judge of complaints made against itself. If “complaints about AHPRA” are filtered, narrowed, or quietly closed by the same institutional chain-of-command that is being complained about, then accountability becomes only a wisp of imagination, not reality. The minimum safeguard is structural: independent receipt, independent triage, transparent reasons for non-investigation, and a review pathway that does not depend on the regulator’s goodwill.
Administrative integrity view:
When an agency demands exhaustive disclosure from clinicians, yet offers minimal disclosure about its own decision-making, the system becomes asymmetric by design.
“Process” turns into a shield: delays, templated reasons are given for inaction, and procedural gates become the method by which uncomfortable complaints are neutralised. A credible scheme must publish service standards, error rates, correction mechanisms, and consequences for staff misconduct — not just expectations for doctors.
Human interest view:
Clinicians expect scrutiny as part of professional life; what corrodes them is the sense of being powerless inside a process that cannot be meaningfully questioned. When complaints about regulatory conduct disappear into opaque channels, doctors stop believing that fairness is possible. The predictable result is emotional withdrawal, risk-avoidant practice, abandonment of complex or high-need patients, and, for many, a quiet decision to leave medicine earlier than planned.
Patient view:
Patients do not benefit from a complaints architecture that only runs downhill. Public safety is not improved by a regulator that cannot be credibly challenged when it gets things wrong. A system that cannot correct itself becomes less accurate over time, and patients ultimately pay the price through reduced access, risk-avoidance, and clinician burnout.
Cynical aside:
If the regulator never has to fear investigation, it will eventually behave like it is above investigation. “We investigated ourselves and found we were satisfactory” is not oversight; it is branding.
